Assisting women to make informed choices about screening for Group B Streptococcus in pregnancy: A critical review of the evidence

Women and Birth

Volumn 26, Issue 2, 2013, Pages 152-157

  Sheehy, Annabel ^a   Davis, Deborah ^b   Homer, Caroline S E ^a  

^a UNIVERSITY OF TECHNOLOGY SYDNEY   (Australia)

^b UNIVERSITY OF CANBERRA   (Australia)

Author keywords

Decision making; Group B Streptococcus; Pregnancy; Screening

Indexed keywords

ANTIBIOTIC AGENT;

FEMALE; FETUS; GROUP B STREPTOCOCCAL INFECTION; HUMAN; MATERNAL CARE; NEWBORN MORTALITY; NOTE; PREGNANCY; PRENATAL EXPOSURE; PRENATAL SCREENING; PREVALENCE; PRIORITY JOURNAL; VERTICAL TRANSMISSION;

ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; AUSTRALIA; DECISION MAKING; FEMALE; HUMANS; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MASS SCREENING; POPULATION SURVEILLANCE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PRENATAL DIAGNOSIS; RISK FACTORS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE;

EID: 84877138721     PISSN: 18715192     EISSN: 18781799     Source Type: Journal    
DOI: 10.1016/j.wombi.2012.10.004     Document Type: Note

References (63)

1. Health N.S.W. Policy directive: neonatal minimisation of early onset group B streptococcal (EOGBS) infection 2005, Deartment of Health, NSW, North Sydney.
2. Royal Prince Alfred Hospital RPA newborn care guidelines: early onset group B streptococcal disease (EOGBSD) 2002, Royal Prince Alfred Hospital, Sydney.
3. The Canberra Hospital, Fetal Medicine Unit Group B streptococcus (GBS) in pregnancy 2011, The Canberra Hospital, Fetal Medicine Unit, Canberra.
4. Health S.A. South Australian Perinatal Practice Guidelines: prevention and treatment of neonatal sepsis (including maternal group B streptococcal colonisation) 2010, Government of South Australia, Adelaide.
5. Connellan M., Wallace E. Prevention of perinatal group B streptococcal disease: screening practice in public hospitals in Victoria. Medical Journal of Australia 2000, 172:317-320.
6. Campbell N., Eddy A., Darlow B., Stone P., Grimwood K. The prevention of early-onset neonatal group B streptococcus infection: technical report from the New Zealand GBS consensus working party. The New Zealand Medical Journal 2004, 117(1200):1-19.
7. UK National Screening Committee Screening for group B streptococcal infection in pregnancy 2012, UK National Screening Committee, London.
8. Ohlsson A., Shah V. Intrapartum antibiotics for known maternal group B streptococcal colonization. Cochrane Database of Systematic Reviews 2009, (3). Art. No.: CD007467. 10.1002/14651858.CD007467.pub2.
9. Van Dyke M.K., Phares C.R., Lynfield R., Thomas A.R., Arnold K.E., Craig A.S., et al. Evaluation of universal antenatal screening for group B streptococcus. New England Journal of Medicine 2009, 360(25):2626-2636.
10. Canadian Task Force on Preventive Health Care Prevention of group B streptococcal infection in newborns: recommendation statement from the Canadian Task Force on Preventative Health Care. JAMC 2002, 166:928-930.
11. Schrag S., Zell E., Lynfield R., Roome A., Arnold K., Craig A., et al. A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates. New England Journal of Medicine 2002, 347:233-240.
12. Phares C., Lynfield R., Farley M., Mohle-Boetani J., Harrison L., Petit S., et al. Epidemiology of invasive group B streptococcal disease in the United States 1999-2005. JAMA 2008, 299:2056-2065.
13. Centers for Disease Control and Prevention Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC, 2010. Morbidity and Mortality Weekly Report 2010, 59(RR-10):1-36.
14. Prevention of early-onset group B streptococcal (GBS) infection in the newborn: systematic review and recommendations 2001, Canadian Task, London, ON. V. Shah, A. Ohlsson, Canadian Task Force on Preventive Health Care (Eds.).
15. Ho C., Chi C., Ho M., Chen C., Liao W., Liu Y., et al. Clinical characteristics of group B streptococcus bacteremia in non-pregnant adults. Journal of Microbiology, Immunology, and Infection 2006, 39:396-401.
16. Law M., Palomaki G., Alfirevic Z., Gilbert R., Heath P., McCartney C., et al. The prevention of neonatal group B streptococcal disease: a report by a working group of the Medical Screening Society. Journal of Medical Screening 2005, 12:60-68.
17. Milner P.J., Smith E.H., Spicer L., Gray J.W. Current and future strategies for prevention of neonatal early-onset group B streptococcus disease. Journal of Pediatric Infectious Diseases 2006, 1(3):127-136.
18. Jeffery H., Mcintosh E. Antepartum screening and non-selective intrapartum chemoprophylaxis for group B streptococcus. Australian and New Zealand Journal of Obstetrics and Gynaecology 1994, 34(1):14-19.
19. Gilbert G., Garland S. Perinatal group B streptococcal infections. Medical Journal of Australia 1983, 1:566-571.
20. Isaacs D., Barfield C., Grimwood K., et al. Systemic bacterial and fungal infections in infants in Australian neonatal units. Medical Journal of Australia 1995, 162:198-201.
21. Freer J. Preventing perinatal transmission of group B streptococcal disease. American Academy of Physician Assistant 2004, 17:47-50.
22. Knox J. Group B streptococcal infection: a review and update. British Journal of Venereal Diseases 1979, 55:118-120.
23. Centers for Disease Control and Prevention Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC 2002. Morbidity and Mortality Weekly Report 2002, 51(RR-11):1-22.
24. Jordan H., Farley M., Craig A., Mohle-Boetani J., Harrison L., Petit S., et al. Revisiting the need for vaccine prevention of late-onset neonatal group B streptococcal disease: a multistate, population-based analysis. Pediatric Infectious Disease Journal 2008, 27(10):1057-1064.
25. Baker C. Group B streptococcal infections. Clinical Perinatology 1997, 24:59-70.
26. Barcaite E., Bartusevicius A., Tameliene R., Kliucinskas M., Maleckiene L., Nadisauskiene R. Prevalence of maternal group B streptococcal colonisation in European countries. Acta Obstetricia et Gynecologica Scandinavica 2008, 87:260-271.
27. Hiller J., McDonald H., Darbyshire P., Crowther C. Antenatal screening for group B streptococcus: a diagnostic cohort study. BioMed Central Pregnancy Childbirth 2005, 5(12). 10.1186/471-2393-5-12.
28. Angstetra D., Fergusen D., Giles W. Institution of universal screening for group B stretococcus (GBS) from a risk management protocol results in reduction of early-onset GBS disease in a tertiary obstetric unit. Australian and New Zealand Journal of Obstetrics and Gynaecology 2007, 47:378-382.
29. Hassan I., Onon T., Weston D., Isalska B., Wall K., Afshar B., et al. A quantitative descriptive study of the prevalence of carriage (colonisation) of haemolytic streptococci groups A, B, C and G in pregnancy. Journal of Obstetrics & Gynaecology 2011, 31(3):207-209.
30. Grimwood K., Stone P.R., Gosling I.A., Green R., Darlow B.A., Lennon D.R., et al. Late antenatal carriage of group B streptococcus by New Zealand women. Australian and New Zealand Journal of Obstetrics and Gynaecology 2002, 42(2):182-186.
31. Money D., Dobson S., Canadian Paediatric Society IDC The prevention of early-onset neonatal group B streptococcal disease. Journal of Obstetrics & Gynaecology Canada: JOGC 2004, 26(9):826-840.
32. Van Dyke M., Phares C., Lynfield R., Thomas A., Arnold K., Craig A., et al. Evaluation of universal antenatal screening for group B streptococcus. New England Journal of Medicine 2009, 360:2626-2636.
33. Centers for Disease Control and Prevention Prevention of perinatal group B streptococcal disease: a public health perspective. Morbidity and Mortality Weekly Report 1996, 45(RR-7).
34. Gilbert R. prenatal screening for group B streptococcal infection: gaps in the evidence. International Journal of Epidemiology 2003, 33(1):2-8.
35. Koenig J.M., Keenan W.J. Group B streptococcus and early-onset sepsis in the era of maternal prophylaxis. Pediatric Clinics of North America 2009, 56(3):689.
36. Boyer K., Gadzala C., Kelly P., Gotoff S. Selective intrapartum chemoprophylaxis of neonatal group B streptococcal early-onset disease. III. Interruption of mother-to-infant transmission. Journal of Infectious Diseases 1983, 148:810-816.
37. Kjaergaarda N., Helmigd R.B., Schønheyderb H.C., Uldbjergd N., Hansenc E.S., Madsena H. Chorioamniotic membranes constitute a competent barrier to group B streptococcus in vitro. European Journal of Obstetrics & Gynecology and Reproductive Biology 1999, 83(2):165-169.
38. Dermer P., Lee C., Eggert J., Few B. A history of neonatal group B streptococcus with its related morbidity and mortality in the United States. Journal of Pediatric Nursing 2004, 19:357-363.
39. Boyer K., Gotoff S. Strategies for chemoprophylaxis of GBS early-onset infections. Antibiotics & Chemotherapy 1985, 35:267-280.
40. Gilbert R. Prenatal screening for group B streptococcal infection: gaps in the evidence. International Journal of Epidemiology 2003, 33:2-8.
41. Heath P., Schuchat A. Perinatal group B streptococcal disease. Best Practice & Research Clinical Obstetrics and Gynaecology 2007, 21(3):411-424.
42. Oddie S., Embleton N., on behalf of the Northern Network Risk factors for early onset neonatal group B streptococcal sepsis: case-control study. BMJ 2002, 325:308-312.
43. Schrag S., Zywicki S., Farley M., Reingold A., Harrison L., Lefkowitz L., et al. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. New England Journal of Medicine 2000, 342:15-21.
44. Centers for Disease Control and Prevention Early-onset and late-onset neonatal group B streptococcal disease - United States, 1996-2004. Morbidity and Mortality Weekly Report 2005, 54:1205-1208.
45. Verani J., McGee L., Schragg S. Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC, 2010. MMWR Recommendation 2010, 59(RR-10):1-31.
46. Schrag S.J.Z.E., Lynfield R., Roome A. A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates. New England Journal of Medicine 2002, 347(4):233-240.
47. RCOG The prevention of early-onset neonatal group B streptococcal disease: green-top guideline no. 36 2012, Royal College of Obstetricains and Gynaecologists, London. 2nd ed.
48. Canadian Task Force on Preventive Health Care Preventions of group B streptococcal infection in newborns: recommendation statement from the Canadian Task Force on Preventative Health Care. JAMC 2002, 166(7):928-930.
49. Tuppurainen N., Hallman M. Prevention of neonatal group B streptococcal disease: intrapartum detection and chemoprohylaxis of heavily colonized parturients. Obsterics & Gynecology 1989, 73:583-587.
50. Matorras R., Garcia-Perea A., Omenaca F., Diez-Enciso M., Madero R., Usandizaga J. Intrapartum chemoprophylaxis of early-onset group B streptococcal disease. European Journal of Obstetrics, Gynecology, and Reproductive Biology 1991, 40:57-62.
51. Easmon C., Hastings M., Deeley J., Bloxham B., Rivers R., Marwood R. The effect of intrapartum chemoprophylaxis on the vertical transmission of group B streptococci. BJOG 1983, 90:633-635.
52. Yow M., Mason E., Leeds L., Thompson P., Clark D., Gardner S. Ampicillin prevents intrapartum transmission of group B streptococci. JAMA 1979, 241:1254-1257.
53. Allardice J., Baskett T., Seshia M., Bowman N., Malazdrewicz R. Perinatal group B streptococcal colonization and infection. American Journal of Obstetrics and Gynecology 1982, 142:617-620.
54. Garland S., Fliegner J. Group B streptococcus (GBS) and neonatal infections: the case for intrapartum chemoprophylaxis. Australian and New Zealand Journal of Obstetrics and Gynaecology 1991, 31:119-122.
55. Allardice J.B.T., Seshia M., Bowman N., Malazdrewicz R. Perinatal group B streptococcal colonization and infection. American Journal of Obstetrics and Gynecology 1982, 142:617-620.
56. Boyer K., Gotoff S. Prevention of early-onset neonatal group B streptococcus disease with selective intrapartum chemoprophylaxis. New England Journal of Medicine 1986, 314:1665-1669.
57. May C., Rapley T., Moreira T., Finch T., Haven B. Technogovernance: evidence, subjectivity and the clinical encounter in primary care medicine. Social Science & Medicine 2006, 62:1022-1030.
58. Schrag S. Email communication: absolute risk reduction for full term infants exposed to culture based screening (vs risk based) for EOGBS 2012, Canberra. L.L. Brunton, B. Chabner, L.S. Goodman, B.C. Knollmann (Eds.).
59. Nathwani D., Morrison J. Parenteral therapy in the outpatient or home setting: evidence, evaluation and future prospects. Journal of Infection 2001, 42:173-175.
60. Petri W. Penicillins, cephalosporins, and other β-lactam antibiotics. The pharmacological basis of therapeutics 2006, McGraw-Hill, New York. 11th ed. L. Brunton, J. Lazo, K. Parker (Eds.).
61. McKernan C. Exploring the literature on delivering home IV therapy. Nursing Times 2008, 104:28-29.
62. Gavin N. Cytotoxic chemotherapy in the home: a study of community nurses' attitudes and concerns. British Journal of Community Nursing 2004, 9:18-24.
63. Trowbridge K., Kralik D. Evidence for intravenous antibiotic therapy in the community. Australian Nursing Journal 2006, 13:28-31.